Sezary Syndrome and Tand#8211;Cell Lymphoma | OMICS International| Abstract
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Clin Pharmacol Biopharm 2017, Vol 6(4): e129
  • DOI: 10.4172/2167-065X.1000e129

Sezary Syndrome and T–Cell Lymphoma

Walaa Fikry Elbossaty*
Department of Chemistry, Biochemistry Division, Damietta University, Damietta, Egypt
*Corresponding Author : Walaa Fikry Elbossaty, Department of Chemistry, Biochemistry Division, Faculty of Science, Damietta University, Damietta, 34517, Egypt, Email: [email protected]

Received Date: Aug 01, 2017 / Accepted Date: Aug 17, 2017 / Published Date: Aug 21, 2017


Lymphoma is a cancer of the white blood cells; the body has two main types of lymphocytes: B lymphocytes, or B-cells, and T lymphocytes. T-cell lymphoma is a disease in which T lymphocyte cells become cancerous. One of the most common forms of T-cell lymphoma is cutaneous, or skin, lymphoma, because it starts in the lymphocytes in the skin. Cutaneous lymphoma actually describes many different disorders with various signs and symptoms, outcomes and treatment considerations. Sézary Syndrome (SS) is characterized by erythroderma, generalized lymphadenopathy, and the presence of circulating atypical lymphocytes, which are difficult to identify by morphologic data.

Keywords: Sezary Syndrome (SS); T-lymphocyte; Blood cancer

Citation: Elbossaty WF (2017) Sezary Syndrome and T–Cell Lymphoma. Clin Pharmacol Biopharm 6: e129. Doi: 10.4172/2167-065X.1000e129

Copyright: © 2017 Elbossaty WF. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 2111
  • [From(publication date): 0-2017 - Apr 20, 2021]
  • Breakdown by view type
  • HTML page views: 1964
  • PDF downloads: 147